検索
Scinai Immunotherapeutics Ltd
SCNIウォッチリストに追加
0.270USD
-0.001-0.29%
終値 07/02, 13:00（ET）15分遅れの株価
956.00K時価総額
損失額直近12ヶ月PER
詳細情報 Scinai Immunotherapeutics Ltd 企業名
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Scinai Immunotherapeutics Ltdの企業情報
企業コードSCNI
会社名Scinai Immunotherapeutics Ltd
上場日Jun 07, 2007
最高経営責任者「CEO」Reichman (Amir)
従業員数31
証券種類Depository Receipt
決算期末Jun 07
本社所在地Jerusalem Biopark, 2Nd Floor
都市JERUSALEM
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号00000
電話番号97289302529
ウェブサイトhttps://www.scinai.com/
企業コードSCNI
上場日Jun 07, 2007
最高経営責任者「CEO」Reichman (Amir)
Scinai Immunotherapeutics Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
--
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
よくある質問
Scinai Immunotherapeutics Ltdの上位5名の株主は誰ですか？
Scinai Immunotherapeutics Ltdの上位5名の株主は以下のとおりです。Mr. Amir Reichman
Scinai Immunotherapeutics Ltd（SCNI）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Scinai Immunotherapeutics Ltdの株式を保有している機関は23社あり、保有株式の総市場価値は約179.71Kで、全体の5.08%を占めています。2025Q4と比較して、機関の持ち株は33890.00増加しています。